Market News AIOpen the app

PHIO stock news · Phio Pharmaceuticals

Stories about Phio Pharmaceuticals (PHIO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PHIO

Follow Phio Pharmaceuticals (PHIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PHIO
Free on the App Store and Google Play, or on the web.
  1. Oct 23, 2026, 5:28 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Friday.

    Neutral

    Phio Pharmaceuticals shares rose 7.65% in the after-market session. The article gives no company update, so it does not change the outlook for Phio Pharmaceuticals' business.

  2. Oct 13, 2026, 8:59 AM ET · Market

    Phio Pharmaceuticals finished its first big batch of PH-762, getting ready for the next trial.

    Good for PHIO

    Phio Pharmaceuticals completed its first commercial-scale PH-762 drug batch, helping prepare for a planned 2027 trial. This is a positive step, though the trial has not begun.

  3. Sep 14, 2026, 9:08 AM ET · Trial

    Phio Pharmaceuticals says it reached an important step for its drug PH-762 and is moving forward with FDA plans.

    Good for PHIO

    Phio said it submitted FDA materials for PH-762 and plans a Phase 2b study; this news supports progress in its clinical program.